4.8 Review

The gut-bone axis: how bacterial metabolites bridge the distance

期刊

JOURNAL OF CLINICAL INVESTIGATION
卷 129, 期 8, 页码 3018-3028

出版社

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI128521

关键词

-

资金

  1. NIH [DK1129461, DK108842, DK119229, RR028009, DK098391]
  2. Else Kroner-Fresenius-Stiftung
  3. Johannes und Frieda Marohn-Stiftung
  4. ELAN program of the Interdisciplinary Center for Clinical Research (IZKF) at the Friedrich-Alexander University Erlangen-Nurnberg
  5. Deutsche Forschungsgemeinschaft (German Research Foundation) [DFG-FOR2886 PANDORA-A01, DFG-CRC1181-B07]
  6. ERC Synergy Grant 4D Nanoscope

向作者/读者索取更多资源

The gut microbiome is a key regulator of bone health that affects postnatal skeletal development and skeletal involution. Alterations in microbiota composition and host responses to the microbiota contribute to pathological bone loss, while changes in microbiota composition that prevent, or reverse, bone loss may be achieved by nutritional supplements with prebiotics and probiotics. One mechanism whereby microbes influence organs of the body is through the production of metabolites that diffuse from the gut into the systemic circulation. Recently, short-chain fatty acids (SCFAs), which are generated by fermentation of complex carbohydrates, have emerged as key regulatory metabolites produced by the gut microbiota. This Review will focus on the effects of SCFAs on the musculoskeletal system and discuss the mechanisms whereby SCFAs regulate bone cells.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据